iRhythm Technologies, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
177.37
+1.17 (0.66%)
Oct 13, 2025, 4:00 PM EDT - Market closed
iRhythm Technologies Employees
iRhythm Technologies had 2,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$328,614
Profits / Employee
-$46,217
Market Cap
5.70B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,000 | 0 | - |
| Dec 31, 2023 | 2,000 | 207 | 11.54% |
| Dec 31, 2022 | 1,793 | 93 | 5.47% |
| Dec 31, 2021 | 1,700 | 543 | 46.93% |
| Dec 31, 2020 | 1,157 | 160 | 16.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IRTC News
- 25 days ago - IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC - GlobeNewsWire
- 4 weeks ago - IRhythm Technologies, Inc. (IRTC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service - GlobeNewsWire
- 7 weeks ago - iRhythm Technologies to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Investor Short Report Flags Steep Downside Risk For iRhythm Technologies - Benzinga
- 2 months ago - AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority - GlobeNewsWire
- 2 months ago - iRhythm Technologies, Inc. (IRTC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - iRhythm Technologies Announces Second Quarter 2025 Financial Results - GlobeNewsWire